Organon signs agreements in Ireland and Brazil:
This article was originally published in Clinica
Executive Summary
Organon Teknika is to distribute Epitope's OraQuick oral fluid rapid test for HIV in Ireland and also Visible Genetics' OpenGene and GeneKits in Brazil. The Irish agreement calls for Organon to collaborate on the final product development and manufacture pre-production lots. The Brazilian deal is a four-year agreement guaranteeing Visible Genetics a minimum annual revenue. The companies say that the deal will open the Latin American market to drug resistance testing.